About
Illumina Connected Insights is a powerful data interpretation platform built for genomics researchers, clinical scientists, and oncology professionals who need to make sense of large-scale NGS data. As part of Illumina's suite of connected informatics products—alongside BaseSpace Sequence Hub, DRAGEN Secondary Analysis, and Illumina Connected Analytics—Connected Insights focuses on the downstream interpretation layer, translating processed sequencing data into meaningful biological and clinical conclusions. The platform is purpose-built for oncology workflows, enabling variant annotation, classification, and reporting aligned with current clinical guidelines. It supports research use only (RUO) and non-IVD contexts, making it suitable for translational research labs and academic medical centers exploring somatic mutations, tumor profiling, and companion diagnostic development. Key capabilities include integration with curated variant databases, structured variant reporting, and support for multi-gene panel interpretation. The tool is designed to reduce the time from sequencing run to clinical-grade report, helping teams prioritize clinically relevant findings and streamline their bioinformatics workflows. Its cloud-based architecture enables scalability and collaboration across distributed teams. Illumina Connected Insights is ideal for molecular pathology labs, genomics core facilities, oncology research teams, and bioinformatics groups looking to operationalize NGS data interpretation without building custom pipelines from scratch.
Key Features
- Oncology-Focused Variant Interpretation: Annotates and classifies somatic variants in the context of oncology guidelines, enabling faster and more confident reporting.
- Cloud-Based Scalability: Operates as a cloud-native solution that scales with sequencing volume and supports distributed team collaboration.
- Integration with Illumina Ecosystem: Connects seamlessly with BaseSpace Sequence Hub, DRAGEN, and Illumina Connected Analytics for end-to-end NGS workflow continuity.
- Structured Clinical Reporting: Generates structured, clinically relevant reports from multi-gene panel data, reducing manual curation and turnaround time.
- Curated Variant Database Access: Leverages curated genomic databases to contextualize variants with evidence-based classifications and literature references.
Use Cases
- Oncology labs using NGS panel data to identify and classify somatic mutations in tumor samples for research reporting.
- Clinical research teams building translational pipelines that bridge sequencing output and structured variant interpretation.
- Molecular pathology departments looking to standardize and accelerate their genomic reporting workflows.
- Academic genomics centers analyzing multi-gene panels for cancer predisposition and tumor profiling studies.
- Bioinformatics groups seeking a managed interpretation layer without building and maintaining custom annotation pipelines.
Pros
- Deep Illumina Ecosystem Integration: Works natively with other Illumina products, reducing friction across the sequencing-to-interpretation pipeline.
- Purpose-Built for Oncology: Specifically tailored for cancer genomics workflows, saving time on customization and validation for somatic variant analysis.
- Cloud-Based Accessibility: Enables remote access and team collaboration without requiring on-premise infrastructure investments.
Cons
- Vendor Lock-In Risk: Tight integration with the Illumina ecosystem may limit flexibility for labs using instruments or reagents from other vendors.
- Enterprise Pricing: Pricing is geared toward institutional and enterprise customers, which may be prohibitive for smaller research labs or startups.
- Limited Public Documentation: Detailed feature specs and workflow documentation are not fully accessible without contacting Illumina's sales team.
Frequently Asked Questions
What is Illumina Connected Insights used for?
It is used for interpreting NGS data, particularly in oncology contexts, helping researchers and clinicians classify variants, generate structured reports, and derive actionable insights from genomic sequencing results.
Is Illumina Connected Insights intended for clinical diagnostics (IVD)?
No. Illumina Connected Insights is labeled as Research Use Only (RUO) and is not intended for use as an In Vitro Diagnostic (IVD) device.
Does Connected Insights work with other Illumina products?
Yes. It integrates with BaseSpace Sequence Hub, DRAGEN Secondary Analysis, and Illumina Connected Analytics as part of a unified informatics ecosystem.
What types of organizations use Illumina Connected Insights?
It is designed for oncology research labs, academic medical centers, molecular pathology departments, and genomics core facilities that process NGS data at scale.
Is training or support available for the platform?
Yes. Illumina offers training resources, webinars, and support services as part of their broader product ecosystem, including Illumina NGS & Array Training and Support Webinars.
